T2 Biosystems

📍 Lexington, United States🗓 Founded 2006👥 140 employees💰 Last funded Jun 2020
Biotechnology🌐 t2biosystems.com
Website LinkedIn
T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers.
2
Total investors
1
Early stage
0
Mid stage
0
Late stage
2006
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in T2 Biosystems?
T2 Biosystems has 2 investors on record on gritt.io, including 1 early-stage backers.
When did T2 Biosystems last raise funding?
The most recent investment in T2 Biosystems recorded on gritt.io was in June 2020.
When was T2 Biosystems founded?
T2 Biosystems was founded in 2006.
What industry is T2 Biosystems in?
T2 Biosystems operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is T2 Biosystems based?
T2 Biosystems is headquartered in Lexington, United States.